Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: A French population-based study

Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, International Journal of Cancer, 127, 2893, 10.1002/ijc.25516 Manfredi, 2006, Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population, British Journal of Surgery, 93, 1115, 10.1002/bjs.5349 McArdle, 2000, ABC of colorectal cancer: effectiveness of follow up, British Medical Journal, 321, 1332, 10.1136/bmj.321.7272.1332 Manfredi, 2006, Epidemiology and management of liver metastases from colorectal cancer, Annals of Surgery, 244, 254, 10.1097/01.sla.0000217629.94941.cf Venderbosch, 2011, Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature, Annals of Surgical Oncology, 18, 3252, 10.1245/s10434-011-1951-5 Ko, 2014, Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases, World Journal of Gastroenterology, 20, 525, 10.3748/wjg.v20.i2.525 Gallagher, 2010, Metastatic colorectal cancer: from improved survival to potential cure, Oncology, 78, 237, 10.1159/000315730 Dawood, 2009, Stereotactic body radiation therapy for liver metastases, European Journal of Cancer, 45, 2947, 10.1016/j.ejca.2009.08.011 Milano, 2012, Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study, International Journal of Radiation Oncology, Biology, Physics, 83, 878, 10.1016/j.ijrobp.2011.08.036 Van Cutsem, 2009, Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer, New England Journal of Medicine, 360, 1408, 10.1056/NEJMoa0805019 Saltz, 2008, Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study, Journal of Clinical Oncology, 26, 2013, 10.1200/JCO.2007.14.9930 Cummings, 2007, Survival after hepatic resection in metastatic colorectal cancer: a population-based study, Cancer, 109, 718, 10.1002/cncr.22448 Leporrier, 2006, A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer, British Journal of Surgery, 93, 465, 10.1002/bjs.5278 Bramhall, 2003, Liver resection for colorectal metastases, Annals of the Royal College of Surgeons of England, 85, 334, 10.1308/003588403769162468 Fong, 1999, Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases, Annals of Surgery, 230, 309, 10.1097/00000658-199909000-00004 Gayowski, 1994, Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors, Surgery, 116, 703 Scheele, 1995, Resection of colorectal liver metastases, World Journal of Surgery, 19, 59, 10.1007/BF00316981 Kato, 2003, Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions, Diseases of the Colon and Rectum, 46, S22 Slesser, 2012, The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review, Clinical and Experimental Metastasis De Jong, 1998, Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors, Hepatology, 28, 971, 10.1002/hep.510280411 van der Wal, 2012, Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil, Annals of Surgery, 255, 86, 10.1097/SLA.0b013e318238346a Mekenkamp, 2010, Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases, British Journal of Cancer, 103, 159, 10.1038/sj.bjc.6605737 Kemeny, 1989, Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvement, Cancer, 63, 742, 10.1002/1097-0142(19890215)63:4<742::AID-CNCR2820630423>3.0.CO;2-T Saltz, 2000, Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group, New England Journal of Medicine, 343, 905, 10.1056/NEJM200009283431302 de Gramont, 2000, Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, Journal of Clinical Oncology, 18, 2938, 10.1200/JCO.2000.18.16.2938 Tournigand, 2004, FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study, Journal of Clinical Oncology, 22, 229, 10.1200/JCO.2004.05.113 Colucci, 2005, Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale, Journal of Clinical Oncology, 23, 4866, 10.1200/JCO.2005.07.113 Nordic Gastrointestinal Tumor Adjuvant Therapy Group, 1992, Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial, Journal of Clinical Oncology, 10, 904, 10.1200/JCO.1992.10.6.904 Graf, 1994, Appraisal of a model for prediction of prognosis in advanced colorectal cancer, European Journal of Cancer, 30A, 453, 10.1016/0959-8049(94)90417-0 Freyer, 2000, Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups, British Journal of Cancer, 83, 431, 10.1054/bjoc.2000.1303 Etienne-Grimaldi, 2008, K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy, Clinical Cancer Research, 14, 4830, 10.1158/1078-0432.CCR-07-4906 Ng, 2009, A preliminary analysis of combined liver resection with new chemotherapy for synchronous and metachronous colorectal liver metastasis, Asian Journal of Surgery, 32, 189, 10.1016/S1015-9584(09)60394-8 Pantaleo, 2008, Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice, British Journal of Cancer, 99, 1729, 10.1038/sj.bjc.6604681 Bockhorn, 2008, Survival of patients with synchronous and metachronous colorectal liver metastases – is there a difference?, Journal of Gastrointestinal Surgery, 12, 1399, 10.1007/s11605-008-0508-9